23andMe Holding Co.

23andMe Holding Co. Fundamental Analysis

MEUSWNASDAQ
HealthcareMedical - Diagnostics & Research
$1.38
$0.13(8.61%)
U.S. Market is Open · 15:26

23andMe Holding Co. Fundamental Analysis

23andMe Holding Co. (MEUSW) shows weak financial fundamentals with a PE ratio of -0.13, profit margin of -1.75%, and ROE of -42.03%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.00

Areas of Concern

ROE-42.03%
Operating Margin-1.83%
Current Ratio0.81
We analyze MEUSW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5402.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5402.8/100

We analyze MEUSW's fundamental strength across five key dimensions:

Efficiency Score

Weak

MEUSW struggles to generate sufficient returns from assets.

ROA > 10%
-85.34%

Valuation Score

Excellent

MEUSW trades at attractive valuation levels.

PE < 25
-0.13
PEG Ratio < 2
-0.00

Growth Score

Weak

MEUSW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

MEUSW shows balanced financial health with some risks.

Debt/Equity < 1
0.83
Current Ratio > 1
0.81

Profitability Score

Weak

MEUSW struggles to sustain strong margins.

ROE > 15%
-4203.21%
Net Margin ≥ 15%
-1.75%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is MEUSW Expensive or Cheap?

P/E Ratio

MEUSW trades at -0.13 times earnings. This suggests potential undervaluation.

-0.13

PEG Ratio

When adjusting for growth, MEUSW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values 23andMe Holding Co. at 0.51 times its book value. This may indicate undervaluation.

0.51

EV/EBITDA

Enterprise value stands at -0.41 times EBITDA. This is generally considered low.

-0.41

How Well Does MEUSW Make Money?

Net Profit Margin

For every $100 in sales, 23andMe Holding Co. keeps $-1.75 as profit after all expenses.

-1.75%

Operating Margin

Core operations generate -1.83 in profit for every $100 in revenue, before interest and taxes.

-1.83%

ROE

Management delivers $-42.03 in profit for every $100 of shareholder equity.

-42.03%

ROA

23andMe Holding Co. generates $-85.34 in profit for every $100 in assets, demonstrating efficient asset deployment.

-85.34%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-2.59 in free cash annually.

$-2.59

FCF Yield

MEUSW converts -4.65% of its market value into free cash.

-4.65%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.13

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.51

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.22

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.83

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-42.03

vs 25 benchmark

ROA

Return on assets percentage

-0.85

vs 25 benchmark

ROCE

Return on capital employed

-3.92

vs 25 benchmark

How MEUSW Stacks Against Its Sector Peers

MetricMEUSW ValueSector AveragePerformance
P/E Ratio-0.1329.45 Better (Cheaper)
ROE-4203.21%417.00% Weak
Net Margin-174.55%-11442.00% (disorted) Weak
Debt/Equity0.830.78 Neutral
Current Ratio0.815.09 Weak Liquidity
ROA-85.34%-74.00% (disorted) Weak

MEUSW outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 23andMe Holding Co.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ